Skip to main content
. 2021 Nov 9;13:8399–8409. doi: 10.2147/CMAR.S332985

Table 3.

Sub-Analysis of Operative Related Data

Characteristics Hyper-Vascular Tumor (Renal Cell Cancer) Hypo-Vascular Tumor Minimally Invasive Tubular Surgery
M (n=3) C (n=4) M (n=11) C (n=16) Hypo-Vascular (n=11) Hyper-Vascular (n=3)
Operation time 283±34 260±42 232±13 240±12 232±13 283±34
Blood loss (mL) 1900±458 1613±652 395±71 1219±175** 395±71 1900±458**
Blood transfusion (mL)
Intraoperative 667±353 800±163 364±85 675±130 364±85 667±353
Within 3 days post operation 667±353 1000±346 364±85 700±139* 364±85 667±353
Drainage
First day (mL) 32±9 244±29** 66±12 294±18** 66±12 32±9
Total amount (mL) 152±61 888±121** 137±40 824±69** 137±40 152±61
Time (day) 4.0±0.6 7.5±0.5** 2.8±0.2 6.4±0.5** 2.8±0.2 4.0±0.6*
Postoperative hospitalization (day) 9.0±1.5 13.3±1.9 8.7±1.2 10.8±0.7 8.7±1.2 9.0±1.5

Notes: *P<0.05 (bold font); **P<0.001 (bold font).